G. Raghu (Seattle, United States of America), M. Ebina (Sendai, Japan)
Effects of aerosolized earthworm fibrinolytic enzyme on bleomycin-induced pulmonary fibrosis in rats Y. Xue, H. Dai, Y. Li, B. Pan, C. Wang (Beijing, China)
| |
Effects of bone marrow mesenchymal stem cells on bleomycin induced pulmonary fibrosis in rats A. Cui, C. Wang, H. Dai, J. Dai, B. Pan (Beijing, China)
| |
Refractory remodeling of lymphatics with rare lymphangiogenesis as a cause of severity of IPF M. Ebina, Y. Kimura, T. Sasaki, S. Koyama, T. Nukiwa (Sendai, Japan)
| |
Noninvasive positive pressure ventilation in patients with acute exacerbation of idiopathic pulmonary fibrosis Y. Kondoh, H. Taniguchi, T. Kimura, O. Nishiyama, K. Kato (Seto, Japan)
| |
Induction of TGF-β and reactive oxygen species expression in bronchial epithelial cell by urban ambient air particulate matter S. H. Jeong, S. Y. Kyung, H. K. Jeon, Y. J. Kim, C. H. An, S. P. Lee, J. W. Park, T. H. Moon, J. K. Lee (Incheon, Republic Of Korea)
| |
Centrilobular fibrosis (CLF): a distinct histological pattern in systemic sclerosis R. B. C. Souza, C. T. L. Borges, V. L. Capelozzi, E. R. Parra, J. Kavakama, R. A. Kairalla, E. Bonfá (São Paulo, Brazil)
| |
Effect of ambulatory oxygen on walking distance in normoxic pulmonary fibrosis P. Sestini, U. Maccari, M. G. Pierobi, K. Archontogeorgis, G. Ciarleglio, N. Nikiforakis, A. Fossi, P. Rottoli (Siena, Italy)
| |
Efficacy and safety of etanercept in patients with idiopathic pulmonary fibrosis (IPF) G. Raghu, S. Fatenejad, L. McDermott, and the IPF Study Group (Seattle, Collegeville, United States Of America)
| |